Acumen Pharmaceuticals
ABOS
ABOS
52 hedge funds and large institutions have $173M invested in Acumen Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+11
Holders Change %
+26.83%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
23
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$2.19M |
| 2 |
2
BlackRock
New York
|
$21M |
| 3 |
SSA
3
Schonfeld Strategic Advisors
New York
|
$585K |
| 4 |
HF
4
HRT Financial
New York
|
$553K |
| 5 |
E
5
Ergoteles
New York
|
$522K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BFC
51
Bedel Financial Consulting
Indianapolis,
Indiana
| $2K | +$2K | +240 | New |
|
52
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$1K | -78 | Closed |
|